Table 1. Correlation between miR-27 expression and clinicopathological characteristics of 60 MM patients.
| Features | Number of cases | miR-27 expression | P-value | |
|---|---|---|---|---|
| High (n=34) | Low (n=26) | |||
| Age (years) | 0.602 | |||
| <55 | 30 | 18 | 12 | |
| ≥55 | 30 | 16 | 14 | |
| Gender | 0.558 | |||
| Female | 29 | 15 | 14 | |
| Male | 31 | 19 | 12 | |
| IMWG risk | 0.008 | |||
| Low risk | 14 | 3 | 11 | |
| Intermediate risk | 18 | 11 | 7 | |
| High risk | 28 | 20 | 8 | |
| ISS stage | 0.025 | |||
| I | 15 | 4 | 11 | |
| II | 19 | 13 | 6 | |
| III | 26 | 17 | 9 | |
| ASCT treatment | 0.463 | |||
| Performed | 27 | 14 | 13 | |
| Not performed | 33 | 20 | 13 | |
| Plasma cell morphology | 0.628 | |||
| Plasmacytic | 18 | 9 | 9 | |
| Plasmablastic | 22 | 12 | 10 | |
| Mixed | 20 | 13 | 7 |
Abbreviations: ASCT, autologous stem cell transplantation; IMWG, International Myeloma Working Group; ISS, International Staging System.